FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely pulmonology, and may be used for prevention of cold bronchospasm in the patients suffering the mixed pathology including bronchial asthma, chronic obstructive pulmonary disease and cold hyperresponsiveness. That is ensured by the single introduction of antasthmatics of 12-24 h action 30 minutes before walking in the open air at Arnoldi temperature (-20°C)-(-50°C). As such preparations, Foradil-combi is introduced in the form of inhalations. 2 inspirations of Budesonide 400 mcg and 1 inspiration of Formoterol 12 mcg, 1 inspiration of Spiriva 18 mcg and oral intake of Singular 10 mg.
EFFECT: method provides effective prevention of cold bronchospasm in the case patients due to the prescribed dose schedule of the antasthmatics ensuring passability of both bronchial tubes, and the whole airway.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ARREST OF COLD BRONCHOSPASM AND MUCOSAL OEDEMA IN PATIENTS WITH BRONCHIAL ASTHMA | 2009 |
|
RU2461395C2 |
METHOD FOR DIAGNOSTICS OF COLD FORM OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2654577C2 |
METHOD OF DIAGNOSTICS OF COLD-INDUCED BRONCHIAL ASTHMA | 2007 |
|
RU2361514C1 |
METHOD FOR TREATMENT OF ASTHMA | 2015 |
|
RU2611406C1 |
METHOD FOR DIAGNOSING COLD AIRWAY HYPERREACTIVITY IN PATIENTS WITH BRONCHIAL ASTHMA | 2022 |
|
RU2794850C1 |
METHOD FOR PREDICTION OF COLD AIRWAY HYPERREACTIVITY CORRECTION EFFICIENCY IN BRONCHIAL ASTHMA PATIENTS WITH APPLICATION OF EXTRA-FINE AEROSOL FOR INHALATIONS OF BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE | 2019 |
|
RU2721415C1 |
METHOD OF TREATMENT OF BRONCHIAL ASTHMA | 2017 |
|
RU2652752C1 |
DIAGNOSTIC BRONCHOALVEOLAR LAVAGE TECHNIQUE | 2007 |
|
RU2417733C2 |
METHOD OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2600833C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF BRONCHIAL ASTHMA | 2008 |
|
RU2391663C1 |
Authors
Dates
2012-09-10—Published
2011-04-08—Filed